Suppr超能文献

组织型纤溶酶原激活剂在脑栓塞模型中的安全性及血管造影疗效

The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.

作者信息

Phillips D A, Fisher M, Smith T W, Davis M A

机构信息

Department of Radiology, University of Massachusetts Medical School, Worcester.

出版信息

Ann Neurol. 1988 Apr;23(4):391-4. doi: 10.1002/ana.410230414.

Abstract

Thrombolysis with tissue plasminogen activator (tPA) has been used to treat myocardial infarction and pulmonary embolism in humans. This plasminogen activator may also be useful in treating certain strokes. We infused tPA or saline in rabbits 15 minutes after selective internal carotid artery embolization with 18-hour aged autologous clot. By serial angiography, the tPA-treated group demonstrated rapid angiographic reperfusion of the occluded vascular territory in 7 of 8 animals, whereas none of 6 saline controls did. None of the animals in either group developed macroscopic cerebral hemorrhage. Both groups showed cerebral infarction, predominantly in the territory of the occluded vessel; the extent of infarction did not differ between tPA-treated animals and controls. Early tPA therapy can allow reperfusion of occluded cerebral arteries safely and effectively in a rabbit cerebral embolization model.

摘要

组织型纤溶酶原激活剂(tPA)溶栓已用于治疗人类心肌梗死和肺栓塞。这种纤溶酶原激活剂可能也有助于治疗某些中风。在用18小时龄的自体血凝块选择性栓塞家兔颈内动脉15分钟后,我们给家兔输注tPA或生理盐水。通过系列血管造影,tPA治疗组的8只动物中有7只显示闭塞血管区域快速血管造影再灌注,而6只生理盐水对照组动物均未出现。两组动物均未发生肉眼可见的脑出血。两组均出现脑梗死,主要在闭塞血管区域;tPA治疗动物和对照组之间的梗死范围无差异。在兔脑栓塞模型中,早期tPA治疗可安全有效地使闭塞脑动脉再灌注。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验